Get the Stockscreener App
19.96
0.20%
0.04
After Hours:
19.96
Enliven Therapeutics Inc stock is traded at $19.96, with a volume of 618.48K.
It is up +0.20% in the last 24 hours and up +5.66% over the past month.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
See More
Previous Close:
$19.92
Open:
$19.9
24h Volume:
618.48K
Relative Volume:
1.20
Market Cap:
$1.18B
Revenue:
-
Net Income/Loss:
$-85.21M
P/E Ratio:
-10.56
EPS:
-1.89
Net Cash Flow:
$-68.53M
1W Performance:
-0.94%
1M Performance:
+5.66%
6M Performance:
-5.04%
1Y Performance:
-10.61%
1-Day Range:
$19.26
$20.15
1-Week Range:
$18.80
$20.82
52-Week Range:
$13.30
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Name
Enliven Therapeutics Inc
Sector
Industry
Phone
720-647-8519
Address
6200 LOOKOUT ROAD, BOULDER
Compare ELVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
19.96 | 1.14B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | Goldman | Buy |
| Dec-13-24 | Initiated | BTIG Research | Buy |
| Sep-09-24 | Initiated | H.C. Wainwright | Buy |
| Jun-11-24 | Initiated | Robert W. Baird | Outperform |
| Apr-09-24 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | Jefferies | Buy |
View All
Enliven Therapeutics Inc Stock (ELVN) Latest News
Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,667 Shares of Stock - MarketBeat
Is Enliven Therapeutics Inc. reversing from oversold territoryInsider Selling & Free Daily Entry Point Trade Alerts - Newser
Why Enliven Therapeutics Inc. is moving todayBreakout Watch & Real-Time Buy Signal Alerts - Newser
Using data models to predict Enliven Therapeutics Inc. stock movement2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Wall Street Analysts Predict a 106.48% Upside in Enliven Therapeutics, Inc. (ELVN): Here's What You Should Know - Yahoo Finance
How to build a custom watchlist for Enliven Therapeutics Inc.Risk Management & Consistent Income Trade Recommendations - Newser
What data driven models say about Enliven Therapeutics Inc.’s futureChart Signals & Stock Timing and Entry Methods - Newser
Can swing trading help recover from Enliven Therapeutics Inc. lossesJuly 2025 Snapshot & Daily Profit Focused Screening - Newser
Advanced analytics toolkit walkthrough for Enliven Therapeutics Inc.Sell Signal & Accurate Technical Buy Alerts - Newser
How to recover losses in Enliven Therapeutics Inc. stockJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - Newser
Candlestick signals on Enliven Therapeutics Inc. stock todayWeekly Stock Analysis & Community Consensus Picks - Newser
Full technical analysis of Enliven Therapeutics Inc. stock2025 Top Gainers & Fast Gaining Stock Reports - Newser
How to interpret RSI for Enliven Therapeutics Inc. stockSell Signal & Fast Exit and Entry Strategy Plans - Newser
Enliven Therapeutics Inc. stock outlook for YEAREarnings Miss & Short-Term High Return Strategies - Newser
How to monitor Enliven Therapeutics Inc. with trend dashboardsEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Is this a good reentry point in Enliven Therapeutics Inc.Weekly Trade Review & Community Consensus Stock Picks - Newser
How to integrate Enliven Therapeutics Inc. into portfolio analysis toolsQuarterly Investment Review & Safe Entry Momentum Tips - Newser
Signal strength of Enliven Therapeutics Inc. stock in tech scannersTrade Signal Summary & Safe Entry Momentum Stock Tips - Newser
Using Bollinger Bands to evaluate Enliven Therapeutics Inc.July 2025 Big Picture & Smart Swing Trading Alerts - Newser
Adage Capital Partners GP L.L.C. Sells 200,000 Shares of Enliven Therapeutics, Inc. $ELVN - MarketBeat
When is the best time to exit Enliven Therapeutics Inc.July 2025 Catalysts & Community Verified Swing Trade Signals - Newser
How to use Fibonacci retracement on Enliven Therapeutics Inc.Breakout Watch & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-09-09 17:50:29 - Newser
Should you wait for a breakout in Enliven Therapeutics Inc.July 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Combining price and volume data for Enliven Therapeutics Inc.July 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Market Review: Will Enliven Therapeutics Inc. benefit from rising consumer demand2025 Key Highlights & Community Verified Watchlist Alerts - Lancaster City Council
Enliven Therapeutics, Inc. (ELVN) Upgraded to Buy: Here's What You Should Know - sharewise.com
Will Enliven Therapeutics Inc. benefit from macro trends2025 Price Targets & Scalable Portfolio Growth Ideas - Newser
What’s Enliven Therapeutics Inc.’s historical returnJuly 2025 Institutional & Reliable Price Breakout Alerts - Lancaster City Council
Can machine learning forecast Enliven Therapeutics Inc. recovery2025 Market Overview & AI Enhanced Execution Alerts - Newser
Applying Elliott Wave Theory to Enliven Therapeutics Inc.Jobs Report & Fast Entry Momentum Trade Alerts - Newser
Published on: 2025-09-09 03:54:01 - Newser
using data tools to time your enliven therapeutics inc. exit2025 Geopolitical Influence & Daily Chart Pattern Signals - Newser
Sector ETF performance correlation with Enliven Therapeutics Inc.Earnings Summary Report & Weekly Top Gainers Alerts - Newser
Analyzing net buyer seller activity in Enliven Therapeutics Inc.2025 Fundamental Recap & Consistent Profit Alerts - Newser
Enliven Therapeutics Inc Stock (ELVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):